GoodRx Holdings, Inc. (GDRX)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 203,070 | 202,970 | 195,251 | 200,610 |
| Sales and marketing | 84,870 | 84,542 | 89,867 | 93,454 |
| Product development and technology | 29,933 | 31,142 | 30,139 | 30,854 |
| General and administrative | 28,379 | 29,630 | 25,619 | 27,589 |
| Depreciation and amortization | 19,729 | 20,912 | 17,535 | 16,965 |
| Cost of revenue, exclusive of depreciation and amortization presented separately below | 13,350 | 13,364 | 11,684 | 11,870 |
| Total costs and operating expenses | 176,261 | 179,590 | 174,844 | 180,732 |
| Operating income | 26,809 | 23,380 | 20,407 | 19,878 |
| Interest expense | - | - | - | 14,566 |
| Loss on extinguishment of debt | - | - | -2,077 | - |
| Other income | 694 | - | -2,660 | - |
| Interest income | 2,803 | 3,932 | 4,797 | 6,334 |
| Interest expense | 10,729 | 10,644 | 12,355 | - |
| Total other expense, net | -7,232 | -6,712 | -12,295 | -8,232 |
| Income before income taxes | 19,577 | 16,668 | 8,112 | 11,646 |
| Income tax expense | 6,734 | 5,616 | 4,147 | 4,952 |
| Net income | 12,843 | 11,052 | 3,965 | 6,694 |
| Basic (in shares) | 356,623,000 | 379,196,000 | 379,667,000 | 376,254,000 |
| Basic (in usd per share) | 0.04 | 0.03 | 0.01 | 0.02 |
| Diluted (in shares) | 357,159,000 | 379,656,000 | 388,504,000 | 384,732,000 |
| Diluted (in usd per share) | 0.04 | 0.03 | 0.01 | 0.02 |